Wilmington, Delaware-based Prelude Therapeutics, a precision oncology company, has raised $50 million in Series C financing. The investors included OrbiMed Advisors LLC and Fidelity Management & Research Company LLC.
Source: Press Release
Prelude Therapeutics snags $50m Series C
Wilmington, Delaware-based Prelude Therapeutics, a precision oncology company, has raised $50 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: